Question 1

What is Thiogenesis Therapeutics Corporation?

Accepted Answer

Thiogenesis Therapeutics Corporation is a Entity.

Question 2

How often does Thiogenesis Therapeutics Corporation appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Thiogenesis Therapeutics Corporation first tracked by Ergen?

Accepted Answer

First tracked on Jun 01, 2026.

Question 4

When was Thiogenesis Therapeutics Corporation last mentioned in news?

Accepted Answer

Last active on Jun 03, 2026.

Question 5

What is Thiogenesis Therapeutics Corporation's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Thiogenesis Therapeutics Corporation in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Thiogenesis Therapeutics Corporation?

Accepted Answer

Thiogenesis Therapeutics Completes C$9.07M Private Placement (Jun 01, 2026, 6 articles).

Question 8

How did the "Thiogenesis Therapeutics Completes C$9.07M Private Placement" event impact Thiogenesis Therapeutics Corporation?

Accepted Answer

Thiogenesis Therapeutics Corporation successfully completed an oversubscribed private placement, raising C$9.07 million, which will fund the clinical development of its drug TTI-0102 and other corporate purposes. This significantly improves its financial position and ability to advance its pipeline.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.